Glibenclamide/metformin

Glibenclamide/metformin
Combination of
Glibenclamide	Sulfonylurea
Metformin	Biguanide
Clinical data
Trade names	Glucovance
Other names	glyburide/metformin
AHFS/Drugs.com	Professional Drug Facts
MedlinePlus	a699055
Pregnancy; category	AU: C ; US: B (No risk in non-human studies) ;
Routes of; administration	By mouth
ATC code	None;
Legal status
Legal status	US: ℞-only ;
Identifiers
KEGG	D10266;

Glibenclamide/metformin, also known as glyburide/metformin and sold under the brand name Glucovance, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes. It contains glibenclamide, a sulfonylureas, and metformin, a biguanide.[1]

References

"Glyburide and metformin hydrochloride tablet". DailyMed. 10 June 2020. Retrieved 11 August 2020.

"Glyburide mixture with Metformin hydrochloride". Drug Information Portal. U.S. National Library of Medicine.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.